Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M; Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Wright A, et al. Among authors: drobniewski f. Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15. Lancet. 2009. PMID: 19375159 Free article. Review.
Worldwide emergence of extensively drug-resistant tuberculosis.
Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. Shah NS, et al. Among authors: drobniewski f. Emerg Infect Dis. 2007 Mar;13(3):380-7. doi: 10.3201/eid1303.061400. Emerg Infect Dis. 2007. PMID: 17552090 Free PMC article.
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group.
Schwoebel V, Lambregts-van Weezenbeek CS, Moro ML, Drobniewski F, Hoffner SE, Raviglione MC, Rieder HL. Schwoebel V, et al. Among authors: drobniewski f. Eur Respir J. 2000 Aug;16(2):364-71. Eur Respir J. 2000. PMID: 10968516 Free article. Review.
Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
Drobniewski F, Rüsch-Gerdes S, Hoffner S; Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Drobniewski F, et al. Clin Microbiol Infect. 2007 Dec;13(12):1144-56. doi: 10.1111/j.1469-0691.2007.01813.x. Epub 2007 Aug 29. Clin Microbiol Infect. 2007. PMID: 17727670 Free article. Review.
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martín-Casabona N, Arias F, Zemanova I, Drobniewski F, Santos Silva A, Coulter C, Lumb R, Cegielski JP. Kurbatova EV, et al. Among authors: drobniewski f. Int J Tuberc Lung Dis. 2012;16(3):355-7. doi: 10.5588/ijtld.11.0542. Int J Tuberc Lung Dis. 2012. PMID: 22640449 Free PMC article.
Recommended standards for modern tuberculosis laboratory services in Europe.
Drobniewski FA, Hoffner S, Rusch-Gerdes S, Skenders G, Thomsen V; WHO European Laboratory Strengthening Task Force. Drobniewski FA, et al. Eur Respir J. 2006 Nov;28(5):903-9. doi: 10.1183/09031936.06.00084906. Epub 2006 Aug 9. Eur Respir J. 2006. PMID: 16899481 Free article.
First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries.
Hillemann D, Hoffner S, Cirillo D, Drobniewski F, Richter E, Rüsch-Gerdes S; Baltic-Nordic TB- Laboratory Network; TB PAN-NET; ECDC ERLN-TB Networks. Hillemann D, et al. Among authors: drobniewski f. PLoS One. 2013 Oct 11;8(10):e76765. doi: 10.1371/journal.pone.0076765. eCollection 2013. PLoS One. 2013. PMID: 24146924 Free PMC article.
Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs.
Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M. Barrera L, et al. Among authors: drobniewski f. Geneva: World Health Organization; 2008. Geneva: World Health Organization; 2008. PMID: 26290924 Free Books & Documents. Review.
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.
Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG, Rüsch-Gerdes S, Mokrousov I, Aleksic E, Allix-Béguec C, Antierens A, Augustynowicz-Kopeć E, Ballif M, Barletta F, Beck HP, Barry CE 3rd, Bonnet M, Borroni E, Campos-Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S, Hanekom M, Hoffner S, Jiao WW, Kalon S, Kohl TA, Kontsevaya I, Lillebæk T, Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng LH, Stakenas P, Toit K, Varaine F, Vukovic D, Wahl C, Warren R, Supply P, Niemann S, Wirth T. Merker M, et al. Among authors: drobniewski f. Nat Genet. 2015 Mar;47(3):242-9. doi: 10.1038/ng.3195. Epub 2015 Jan 19. Nat Genet. 2015. PMID: 25599400 Free PMC article.
286 results